FilingIndex
10-QThe Record

Janux Therapeutics, Inc. files 10-Q

Filed Nov 10, 2022 · 3y ago · Accession 0000950170-22-024511

Plain English

Quarterly report — three-month financials and management discussion.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
JANX
CIK
1817713
Form type
10-Q
Filing date
Nov 10, 2022
Report date
Sep 30, 2022
Document
janx-20220930.htm
Size
11.0 MB